< Back to Article

Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis

Fig 5

Estimated probability of cost-effective and cost-saving policy over the 20-year simulated period.

Cost-effectiveness at the willingness to pay value of $100,000 per quality-adjusted life year.

Fig 5